Cited by 15

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Discovery of simplified leucyladenylate sulfamates as novel leucyl-tRNA synthetase (LRS)-targeted mammalian target of rapamycin complex 1 (mTORC1) inhibitors

Yoon, Suyoung, Kim, Jong Hyun, Koh, Yura, Tran, Phuong-Thao, Ann, Jihyae, Yoon, Ina, Jang, Jayun, Kim, Won Kyung, Lee, Sangkook, Lee, Jiyoun, Kim, Sunghoon, Lee, Jeewoo·2017·Bioorganic & Medicinal Chemistry

Abstract

Leucyl-tRNA synthetase (LRS) has been reported to be a possible mediator of intracellular amino acids signaling to mTORC1. Given that mTORC1 is associated with cell proliferation and tumorigenesis, the LRS-mediated mTORC1 pathway may offer an alternative strategy in anticancer therapy. In this study, we developed a series of simplified analogues of leucyladenylate sulfamate (1) as LRS-targeted mTORC1 inhibitors. We replaced the adenylate group with a N-(3,4-dimethoxybenzyl)benzenesulfonamide (2a) or a N-(2-phenoxyethyl)benzenesulfonamide groups (2b) that can maintain specific binding, but has more favorable physicochemical properties such as reduced polarity and asymmetric centers. Among these simplified analogues, compound 16 and its constrained analogue 22 effectively inhibited S6K phosphorylation in a dose-dependent manner and exhibited cancer cell specific cytotoxicity against six different types of cancer cells. This result supports that LRS is a viable target for novel anticancer therapy.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.bmc.2017.06.002

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 20

  1. Laplante, 2012, Cell, 149, 274, 10.1016/j.cell.2012.03.017 · DOI · Paper page
  2. Bjornsti, 2004, Nat Rev Cancer, 4, 335, 10.1038/nrc1362 · DOI
  3. Benjamin, 2011, Nat Rev Drug Discov, 10, 868, 10.1038/nrd3531 · DOI
  4. Chiang, 2007, Trends Mol Med, 13, 433, 10.1016/j.molmed.2007.08.001 · DOI
  5. Guertin, 2007, Cancer Cell, 12, 9, 10.1016/j.ccr.2007.05.008 · DOI · Paper page
  6. Hudes, 2007, N Engl J Med, 356, 2271, 10.1056/NEJMoa066838 · DOI
  7. Motzer, 2008, Lancet, 372, 449, 10.1016/S0140-6736(08)61039-9 · DOI · Paper page
  8. Thoreen, 2009, Autophagy, 5, 725, 10.4161/auto.5.5.8504 · DOI
  9. Chiarini, 2015, Trends Pharmacol Sci, 36, 124, 10.1016/j.tips.2014.11.004 · DOI
  10. Strimpakos, 2009, Cancer Treat Rev, 35, 148, 10.1016/j.ctrv.2008.09.006 · DOI
  11. Stipanuk, 2007, Nutr Rev, 65, 122, 10.1111/j.1753-4887.2007.tb00289.x · DOI
  12. Dodd, 2012, Am J Physiol Endocrinol Metab, 302, E1329, 10.1152/ajpendo.00525.2011 · DOI
  13. Han, 2012, Cell, 149, 410, 10.1016/j.cell.2012.02.044 · DOI · Paper page
  14. Bonfils, 2012, Mol Cell, 46, 105, 10.1016/j.molcel.2012.02.009 · DOI
  15. Lynch, 2000, J Cell Biochem, 77, 234, 10.1002/(SICI)1097-4644(20000501)77:2<234::AID-JCB7>3.0.CO;2-I · DOI
  16. Wang, 2008, J Biol Chem, 283, 30482, 10.1074/jbc.M803348200 · DOI
  17. Yoon, 2016, J Med Chem, 59, 10322, 10.1021/acs.jmedchem.6b01190 · DOI · Paper page
  18. Yoon, 2016, Bioorg Med Chem Lett, 26, 3038, 10.1016/j.bmcl.2016.05.011 · DOI · Paper page
  19. Filippov, 1998, Tetrahedron Lett, 39, 4891, 10.1016/S0040-4039(98)00888-0 · DOI
  20. Vichai, 2006, Nat Protoc, 1, 1112, 10.1038/nprot.2006.179 · DOI

Cited by

Sorted by citations

See all 15

Metadata

Authors
Yoon, S., Kim, J. H., Koh, Y., Tran, P.-T., Ann, J., Yoon, I., Jang, J., Kim, W. K., Lee, S., Lee, J., Kim, S., & Lee, J.
Venue
Bioorganic & Medicinal Chemistry
Publisher
Elsevier BV
Published
2017-08
Volume
25
Issue
15
Pages
4145-4152
ISSN
0968-0896
Cited by
15
References
1
Language
en
Funders
Ministry of Education, Science and Technology of Korea (NRF-2012M3A6A4054928)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review